AI assistant
Sending…
Vir Biotechnology, Inc. — Director's Dealing 2021
Dec 2, 2021
32538_dirs_2021-12-01_c1820474-4e77-4ff5-8ace-dfcdfaf8c915.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2021-11-29
Reporting Person: HANLY ANN M. (Chief Technology Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-29 | Common Stock | P | 11.52 | $43.39 | Acquired | 11.52 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 30600 | Direct |
Footnotes
F1: The purchase was effectuated by a minor through a trading account registered in the name of the reporting person's spouse.
F2: Includes 600 shares of common stock acquired by the reporting person on November 30, 2021 pursuant to an employee stock purchase program.
More from Vir Biotechnology, Inc.
Board/Management Information
2026
Jun 10
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Proxy Solicitation & Information Statement
2026
Apr 16
Board/Management Information
2026
Apr 10
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Regulatory Filings
2026
Mar 23
Board/Management Information
2026
Mar 4
Director's Dealing
2026
Mar 3
Capital/Financing Update
2026
Mar 2